Latest Dolasetron Stories

2008-01-29 15:00:13

Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EMEND(R) (fosaprepitant dimeglumine) for Injection, a new intravenous therapy for the prevention of chemotherapy-induced nausea and vomiting (CINV). EMEND for Injection is an intravenous prodrug of the oral formulation of EMEND(R) (aprepitant), which means that when EMEND for Injection is administered, fosaprepitant is rapidly converted in the body to aprepitant. EMEND for Injection is approved...

2006-05-02 08:00:00

NEW YORK -- Acupuncture, in conjunction with the latest drugs to prevent nausea and vomiting, seems to help relieve chemotherapy-induced vomiting, a new report suggests. Despite the advent of new drug that control nausea and vomiting related to chemotherapy (anti-emetics), many cancer patients still experience these unpleasant side effects, which can impair quality of life, cause emotional distress, and aggravate cancer-related symptoms such as weight loss, lethargy and weakness. The ancient...

Word of the Day
  • Boughs or branches.
  • Warbling of birds in trees.